PI3K and negative regulation of TLR signaling

Trends in Immunology

Volumn 24, Issue 7, 2003, Pages 358-363

  Fukao, Taro ^a   Koyasu, Shigeo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE M; INTERLEUKIN 12; INTERLEUKIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN; SUPPRESOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; WORTMANNIN;

CELL ACTIVITY; CELL POLARITY; CELL TYPE; CYTOKINE PRODUCTION; DRUG TARGETING; EXPOSURE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; MACROPHAGE; MOLECULAR MECHANICS; NEGATIVE FEEDBACK; NONHUMAN; PATHOGENICITY; POLARIZATION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STIMULATION; TH1 CELL; TREATMENT INDICATION;

EID: 0037629646     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00139-X     Document Type: Article

References (48)

1. Ulevitch R.J., Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:1995;437-449.
2. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:2001;135-145.
3. Takeda K., et al. Toll-like receptors. Annu. Rev. Immunol. 21:2003;335-376.
4. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
5. H2 development. Nat. Immunol. 1:2000;199-205.
6. Zeisberger E., Roth J. Tolerance to pyrogens. Ann. New York Acad. Sci. 856:1998;116-122.
7. Zeigler-Heitbrock H.W. Molecular mechanism in tolerance to lipopolysaccharide. J. Inflamm. 45:1995;13-26.
8. Nomura F., et al. Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J. Immunol. 164:2000;3476-3479.
9. Zeigler-Heitbrock H.W., et al. Tolerance to lipopolysaccharide involves mobilization of nuclear factor κB with predominance of p50 homodimers. J. Biol. Chem. 269:1994;17001-17004.
10. Kobayashi K., et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 110:2002;191-202.
11. Kinjyo I., et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity. 17:2002;583-591.
12. Nakagawa R., et al. SOCS-1 participates in negative regulation of LPS responses. Immunity. 17:2002;677-687.
13. Fukao T., et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3:2002;875-881.
14. Guha M., Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277:2002;32124-32132.
15. Fukao T., et al. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat. Immunol. 3:2002;295-304.
16. Hirsch E., et al. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science. 287:2000;1049-1053.
17. Sasaki T., et al. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science. 287:2000;1040-1046.
18. Li Z., et al. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science. 287:2000;1046-1049.
19. Okkenhaug K., et al. Impaired B and T cell antigen receptor signaling in p110δ PI3-kinase mutant mice. Science. 297:2002;1031-1034.
20. Clayton E., et al. A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 196:2002;753-763.
21. Herrera-Velit P., et al. Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-ζ in bacterial lipopolysaccharide-treated human monocytes. J. Biol. Chem. 272:1997;16445-16452.
22. Arbibe L., et al. Toll-like receptor 2-mediated NF-κB activation requires a Rac1-dependent pathway. Nat. Immunol. 1:2000;533-540.
23. Baek K.H., et al. A novel function of phosphorothioate oligodeoxynucleotides as chemoattractants for primary macrophages. J. Immunol. 167:2001;2847-2854.
24. Ren C.L., et al. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C γ 2. J. Exp. Med. 179:1994;673-680.
25. Wong B.R., et al. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell. 4:1999;1041-1049.
26. Imler J.L., Hoffmann J.A. Toll signaling: the TIReless quest for specificity. Nat. Immunol. 4:2003;105-106.
27. Lee J., et al. TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J. Leukoc. Biol. 68:2000;909-915.
28. Wang C., et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 412:2001;346-351.
29. Ojaniemi M., et al. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 33:2003;597-605.
30. Lu H.T., et al. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18:1999;1845-1857.
31. Kim A.H., et al. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 21:2001;893-901.
32. Gratton J.P., et al. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J. Biol. Chem. 276:2001;30359-30365.
33. Toker A., Cantley L.C. Signaling through the lipid products of phosphoinositide-3-OH kinase. Nature. 387:1997;673-676.
34. Sizemore N., et al. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit. Mol. Cell. Biol. 19:1999;4798-4805.
35. Gately M.K., et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:1998;495-521.
36. + T-cell subsets in autoimmunity. Curr. Opin. Immunol. 9:1997;872-883.
37. Fong L., Engleman E.G. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18:2000;245-273.
38. Neurath M.F., et al. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8:2002;567-573.
39. Stein R.C., Waterfield M.D. PI3-kinase inhibition: a target for drug development? Mol. Med. Today. 6:2000;347-357.
40. Re F., Strominger J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276:2001;37692-37699.
41. Jones B.W., et al. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann. Rheum. Dis. 60:2001;6-12.
42. Monick M.M., et al. Phosphatidylinositol 3-kinase activity negatively regulates stability of cyclooxygenase 2 mRNA. J. Biol. Chem. 277:2002;32992-33000.
43. Diaz-Guerra M.J., et al. Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. J. Immunol. 162:1999;6184-6190.
44. Park Y.C., et al. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, enhances LPS-induced NO production from murine peritoneal macrophages. Biochem. Biophys. Res. Commun. 240:1997;692-696.
45. Bowling W.M., et al. Inhibition of phosphatidylinositol-3′-kinase prevents induction of endotoxin tolerance in vitro. J. Surg. Res. 63:1996;287-292.
46. Ishii K.J., et al. Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation. J. Exp. Med. 196:2002;269-274.
47. Park Y., et al. CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3′-OH kinase pathway. J. Immunol. 168:2002;5-8.
48. Baek K.H., et al. A novel function of phosphorothioate oligodeoxynucleotides as chemoattractants for primary macrophages. J. Immunol. 167:2001;2847-2854.